UK NHS slammed for poor hospital infection controls - full screening ahead?
This article was originally published in Clinica
"More than four years have passed since our predecessor committee first highlighted the paucity of information on the extent and cost of hospital acquired infection, yet today we find that little has been done to dispel this fog of ignorance." So says the UK Parliament's Public Accounts Committee of a stinging report it released last week, which provides the strongest arguments yet for comprehensive screening in healthcare facilities.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.